Harvard Bioscience (HBIO) Misses Q3 EPS by 2c

October 29, 2015 8:53 AM EDT

Harvard Bioscience (NASDAQ: HBIO) reported Q3 EPS of $0.03, $0.02 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $25.7 million versus the consensus estimate of $27.01 million.

For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings